BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 17158926)

  • 1. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
    Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
    Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II histone deacetylases: structure, function, and regulation.
    Bertos NR; Wang AH; Yang XJ
    Biochem Cell Biol; 2001; 79(3):243-52. PubMed ID: 11467738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1.
    Taplick J; Kurtev V; Kroboth K; Posch M; Lechner T; Seiser C
    J Mol Biol; 2001 Apr; 308(1):27-38. PubMed ID: 11302704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor.
    De Luca A; Severino A; De Paolis P; Cottone G; De Luca L; De Falco M; Porcellini A; Volpe M; Condorelli G
    Biochem J; 2003 Feb; 369(Pt 3):477-84. PubMed ID: 12371907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
    Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
    Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of N-CoR and histone deacetylase 3 by the oncoprotein v-erbA yields a chromatin infrastructure-dependent transcriptional repression pathway.
    Urnov FD; Yee J; Sachs L; Collingwood TN; Bauer A; Beug H; Shi YB; Wolffe AP
    EMBO J; 2000 Aug; 19(15):4074-90. PubMed ID: 10921888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3.
    Wang L; Hiebert SW
    Oncogene; 2001 Jun; 20(28):3716-25. PubMed ID: 11439334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylation inactivates the transcriptional repressor BCL6.
    Bereshchenko OR; Gu W; Dalla-Favera R
    Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of NF-kappaB action by reversible acetylation.
    Greene WC; Chen LF
    Novartis Found Symp; 2004; 259():208-17; discussion 218-25. PubMed ID: 15171256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC4 deacetylase associates with and represses the MEF2 transcription factor.
    Miska EA; Karlsson C; Langley E; Nielsen SJ; Pines J; Kouzarides T
    EMBO J; 1999 Sep; 18(18):5099-107. PubMed ID: 10487761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
    Leong GM; Subramaniam N; Issa LL; Barry JB; Kino T; Driggers PH; Hayman MJ; Eisman JA; Gardiner EM
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1070-6. PubMed ID: 14985122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases.
    Lu J; McKinsey TA; Nicol RL; Olson EN
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4070-5. PubMed ID: 10737771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation.
    Watamoto K; Towatari M; Ozawa Y; Miyata Y; Okamoto M; Abe A; Naoe T; Saito H
    Oncogene; 2003 Dec; 22(57):9176-84. PubMed ID: 14668799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEF-1 and MEF2 transcription factors interact to regulate muscle-specific promoters.
    Maeda T; Gupta MP; Stewart AF
    Biochem Biophys Res Commun; 2002 Jun; 294(4):791-7. PubMed ID: 12061776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of nuclear receptors and cofactors in human endometrium and myometrium.
    Vienonen A; Miettinen S; Bläuer M; Martikainen PM; Tomás E; Heinonen PK; Ylikomi T
    J Soc Gynecol Investig; 2004 Feb; 11(2):104-12. PubMed ID: 14980312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of class II histone deacetylases.
    Fischle W; Kiermer V; Dequiedt F; Verdin E
    Biochem Cell Biol; 2001; 79(3):337-48. PubMed ID: 11467747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.
    Sun L; Liu L; Yang XJ; Wu Z
    J Cell Sci; 2004 Jun; 117(Pt 14):3021-9. PubMed ID: 15173318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of transcription factor YY1 by acetylation and deacetylation.
    Yao YL; Yang WM; Seto E
    Mol Cell Biol; 2001 Sep; 21(17):5979-91. PubMed ID: 11486036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
    McKinsey TA; Zhang CL; Lu J; Olson EN
    Nature; 2000 Nov; 408(6808):106-11. PubMed ID: 11081517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.